Population
Patients with arterial diseases
Design
Review
Authors
Loading...
Genotype-guided P2Y12 selection may reduce bleeding without excess ischemia in PCI; leaves open routine adoption pending further randomized confirmation.
This paper reviews pharmacogenetic considerations in the use of oral antiplatelet therapy (aspirin and P2Y12 receptor blockers) for preventing thrombotic events.
Gurbel et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: